AffloVest® Mobile Airway Clearance Therapy with Direct Dynamic Oscillation™ is for mobilizing and clearing secretions for patients with severe respiratory diseases such as bronchiectasis, cystic fibrosis and other neuromuscular diseases, and is fully mobile during use.
The Colton Underwood Legacy Foundation and International Biophysics, the manufacturer of the AffloVest Mobile Airway Clearance Therapy vest, have partnered to bring 50 Cystic Fibrosis patients next generation treatment to those who need it most. See the press release here
Is it more than COPD? Do you have frequent chest infections, hospitalizations, multiple rounds of antibiotics, tried other treatments that failed? You may be one of an estimated 5 million COPD patients that may have BRONCHIECTASIS. Ask your doctor about screening for bronchiectasis and whether Mobile Airway Clearance Therapy is for you. Learn more here and get your free resource kit
Frequent chest infections, hospitalizations, and failed treatments may indicate the need for screening for bronchiectasis. Is this you?
Dr. Alan Barker, MD, discusses breaking the vicious cycle of bronchiectasis and the role of Airway Clearance Therapy
AffloVest HFCWO Mobile Airway Clearance Vest Therapy with Direct Dynamic Oscillation™, see how it works.
The proof is in the data.
Multiple clinician papers confirm results we’ve seen before – improved patient lung function with AffloVest® by International Biophysics. Average FVC, FEV1, and FEF 25-75% scores increased 15.22%, 17.41%, and 11.21% respectively.
Your doctor may prescribe the Afflovest if you have one of the following conditions*:
- Cystic Fibrosis
- Late Effects of poliomyelitis
- Other deficiencies of circulating enzymes
- Anterior horn cell diseases
- Multiple sclerosis
- Muscular dystrophy
- Myotonic disorders
- Disorders of the diaphragm
“It is hard to believe there is actually a company with people like you who really care, listen and then follow through.”
The AffloVest is battery operated and uses Direct Dynamic Oscillation™ technology that closely mimics hand CPT to help mobilize and clear secretions, allowing for full freedom of mobility during treatment. The AffloVest features 8 built-in oscillating modules that, for the full range of sizes offered, are anatomically placed to target the lobes of the lung and allow for targeted customized treatment plans using the digital controller.
The AffloVest pioneered mechanical oscillation airway clearance therapy for patients with severe respiratory diseases such as bronchiectasis, cystic fibrosis, and other neuromuscular diseases. International Biophysics has a 25-year pedigree of successful medical product and technology launches around the globe.*
* AffloVest requires a doctor’s prescription for treatment by High Frequency Chest Wall Oscillation (HFCWO). The AffloVest has received the FDA’s 510k clearance for U.S. market availability, and is approved for Medicare and private health insurance reimbursement under the Healthcare Common Procedure Coding System (HCPCS) code E0483 – High Frequency Chest Wall Oscillation.
** Patients must qualify to meet eligibility requirements.